These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3562976)

  • 1. [Lipoprotein indexes in coronary atheromatosis].
    Pintó Sala J; Fiol Castaño C; Bros Caimari R; Marcos Vidal C
    Rev Clin Esp; 1987 Jan; 180(1):59-60. PubMed ID: 3562976
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: correlation with the severity of atheromatosis.
    Lima LM; Sousa MO; Dusse LM; Lasmar MC; das Graças Carvalho M; Lwaleed BA
    Thromb Res; 2007; 121(2):283-7. PubMed ID: 17582470
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].
    Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-insulin-dependent diabetes mellitus and atherosclerosis: a lipoprotein perspective.
    Hamsten A; Steiner G
    J Intern Med Suppl; 1994; 736():1-3. PubMed ID: 7986301
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the coronary risk: is it enough to asses ApoB/ApoA1 ratio only or is plasma lipoprotein concentration still necessary?].
    Cybulska B
    Kardiol Pol; 2005 Feb; 62(2):153-6. PubMed ID: 15815801
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of lipoprotein levels with atherosclerotic changes in patients with coronary artery spasm and insignificant coronary artery stenosis.
    Koh KK; Lee KH; Cho SK; Kim SS; Kim JJ; Lee YH
    Coron Artery Dis; 1995 Mar; 6(3):235-9. PubMed ID: 7788036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma lipoproteins and coronary arteriosclerosis].
    Sznajderman M
    Przegl Lek; 1987; 44(6):508-9. PubMed ID: 3685436
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum remnant lipoprotein levels in nephrotic syndrome.
    Kinoshita H; Uezono S; Fukudome K; Yokota N; Hisanaga S; Fujimoto S; Eto T
    Clin Nephrol; 2001 Mar; 55(3):263-4. PubMed ID: 11316252
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation between alcohol intake, lipoproteins and coronary heart disease: the interest continues.
    Srivastava LM; Vasisht S; Agarwal DP; Goedde HW
    Alcohol Alcohol; 1994 Jan; 29(1):11-24. PubMed ID: 8003112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aspects in lipidology and atherosclerosis.
    Superko HR
    Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
    Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
    Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of TF and TFPI activities in patients with hypertension or coronary atherosclerotic heart disease].
    Xiao Z; Wang W; Han J; He X; Li J
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):251-2, 255. PubMed ID: 12016797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of atherosclerosis.
    Segrest JP; Anantharamaiah GM
    Curr Opin Cardiol; 1994 Jul; 9(4):404-10. PubMed ID: 7919584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipoprotein (a): variability and association with coronary disease].
    Souza DR; Garcia MV
    Arq Bras Cardiol; 1994 Mar; 62(3):187-94. PubMed ID: 7980082
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum levels of nitric oxide end products and interactions with lipoproteins in patients with coronary artery disease.
    Afrasyap L; Oztürk G; Erbaş D
    Clin Lab; 2004; 50(11-12):703-7. PubMed ID: 15575313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of apolipoproteins in dyslipidemias].
    Quintão EC
    Arq Bras Cardiol; 1988 Feb; 50(2):129-34. PubMed ID: 3063237
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of a new polymorphism in the human apolipoprotein A-I gene: association with serum lipoprotein levels and coronary heart disease.
    Bai H; Saku K; Liu R; Jimi S; Arakawa K
    J Cardiol; 1996 Oct; 28(4):207-12. PubMed ID: 8934336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modified lipoproteins--their types and role in atherogenesis].
    Bratus' VV; Talaieva TV; Lomakovs'kyĭ OM; Tretiak IV; Radalovs'ka NV
    Fiziol Zh (1994); 2000; 46(2):73-81. PubMed ID: 10867865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease.
    Sarkar PD; T M S; Madhusudhan B
    Clin Chim Acta; 2006 Nov; 373(1-2):77-81. PubMed ID: 16797516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.